Metastatic Cholangiocarcinoma

12 clinical trials · Condition

Record	Firm	Date
Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma (NCT04088188)	Academic and Community Cancer Research United	2021-01-25
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies (NCT04068194)	National Cancer Institute (NCI)	2020-04-07
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver (NCT04175912)	National Cancer Institute (NCI)	2020-03-16
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors (NCT02757391)	M.D. Anderson Cancer Center	2019-08-09
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma (NCT03656536)	Incyte Corporation	2019-06-03
Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer (NCT03201458)	National Cancer Institute (NCI)	2018-02-08
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma (NCT03250273)	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	2017-11-06
Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) (NCT02989857)	Institut de Recherches Internationales Servier	2017-02-20

Track Metastatic Cholangiocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.